Serial angiographic follow-up after successful direct angioplasty for acute myocardial infarction

American Journal of Cardiology

Volumn 78, Issue 9, 1996, Pages 980-984

  Nakagawa, Yoshihisa ^a   Iwasaki, Yoshihiro ^a   Kimura, Takeshi ^a   Tamura, Takashi ^a   Yokoi, Hiroyoshi ^a   Yokoi, Hiroatsu ^a   Hamasaki, Naoya ^a   Nosaka, Hideyuki ^a   Nobuyoshi, Masakiyo ^a  

^a KOKURA MEMORIAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; MALE; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; RECURRENT DISEASE; TIME;

AGED; ANGIOPLASTY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECURRENCE; TIME FACTORS;

EID: 0030293294     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00520-6     Document Type: Article

References (24)

1. Hartzier GO, Rutherford BD, McConahay DR, Johnson WL Jr, McCallister BD, Gura GM, Conn RC, Crockett JE. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 1986;106:965-973.
2. O'Keefe JH Jr, Rutherford BD, McConahay DR, Ligon RW, Johnson WL, Giorgi LV, Crockett JE, McCallister BD, Conn RD, Gura GM, et al. Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1989;64:1221-1230.
3. Ellis SG, O'Neill WW, Bates ER, Walton JA, Nabel EG, Topol EJ. Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience. J Am Coll Cardiol 1989;13:1122-1126.
4. Rothbaum DA, Linnemeier TJ, Landin RJ, Steinmetz EF, Hillis JS, Hallam CC, Nobel RJ, See MR. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience. J Am Coll Cardiol 1987;10:264-272.
5. Simoons ML, Serruys PW, van den Brand M, Res J, Verbeugt PWA, Krauss XH, Remme WJ, Bar F, Zwann C, van der Laarse A, Vermeer F, Lubsen J. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol 1986;7:717-782.
6. Gruppo Italiano per lo Studio della Streptochinasi Nell'Infarto Miocardio (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
7. Wilcox RG, van der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction; Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988;2:525-530.
8. ISIS-2 (Second International Study of Infarct Survival) collaborative group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-360.
9. Cragg DR, Friedman HZ, Bonema JD, Jaiyesimi IA, Ramos RG, Timmis GC, O'Neill WW, Schreiber TL. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. Ann Intern Med 1991;115:173-177.
10. Topol EJ, George BS, Kereiakes DJ, Stump DC, Candela RJ, Abbottsmith CW, Aronson L, Pickel A, Boswick JM, Lee KL, Ellis SG, Califf RM, and the TAMI study group. A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction. Circulation 1989;79:281-286.
11. Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ, Lee KL, Pitt B, Stack RS, O'Neill WW. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987;317:581-588.
12. Grines CL, Nissen SE, Booth DC, Gurley JC, Chelliah N, Wolf R, Blankenship J, Branco MC, Bennett K, DeMaria AN, and the Kentucky Acute Myocardial Infarction Trial (KAMIT) group. A prospective, randomized trial combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Circulation 1991;84:540-549.
13. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, et al. Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987;76:142-154.
14. Grines CL, Browne KF, Marco J, Bothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC, et al, for the primary angioplasty in myocardial infarction study group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-679.
15. Zijlstra F, de Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-684.
16. Brodie BR, Grines CL, Ivanhoe R, Knopf W, Taylor G, O'Keefe J, Weintraub RA, Berdan LG, Techeng JE, Woodlief IH, Califf RM, O'Neill WW. Sixmonth clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction: final results from the primary angioplasty registry. Circulation 1994;25:156-162.
17. Miller PF, Brodie BR, Weintraub RA, LeBauer EJ, Katz JD, Stuckey TD, Hansen CJ. Emergency coronary angioplasty for acute myocardial infarction: results from a community hospital. Arch Intern Med 1987;147:1555-1570.
18. Brodie BR, Stuckey TD, Hansen CJ, Cooper TR, Weintraub RA, LeBauer EJ, Katz JD, Kelly TA. Importance of a patent infarct-related artery for hospital and late survival after direct coronary angioplasty for acute myocardial infarction. Am J Cardiol 1992;69:1113-1119.
19. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohislii H. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988;12:616-623.
20. Serruys PW, Beatl LK, Geuskens BR, de Feyter PJ, van den Brand M, Reiber JHC, ten Katen HJ, van Es GA, Hugenholtz PG. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3 and 4 months. Circulation 1988;77:361-371.
21. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein Ilb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
22. Schömig A, Kastrati A, Mudra H, Blasini R, Schühlen H, Klauss B, Rihardt G, Neumann FJ. Four year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation 1994;90:2716-2724.
23. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, et al, for the Stent Restenosis Study investigators. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
24. Wong PC, Wong CM. Intracoronary stenting in acute myocardial infarction. Cathet Cardiovasc Diagn 1994;33:39-45.